Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Herbert G. Sayer, MD, Anne Klink, Thomas Schenk, MD, Anne Treschl, MD, Kristina Schilling, MD, Andreas Hochhaus, MD

Blood (2010) 116 (21): 2325.

https://doi.org/10.1182/blood.V116.21.2325.2325

Published: 2010

Journal Articles

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

Herbert G. Sayer, Lars-Olof Mügge, Sebastian Scholl, Anne Klink, Kristina Schilling, Klaus Höffken

Blood (2008) 112 (11): 2202.

https://doi.org/10.1182/blood.V112.11.2202.2202

Published: 2008

Journal Articles

High Overall Response Rate in Calcineurin Inhibitor-Free Treatment with the mTOR Inhibitor Everolimus in Advanced Extensive Chronic GvHD after Allogeneic Stem Cell Transplantation.

Anne Klink, Kristina Schilling, Katrin Rapp, Klaus Höffken, Herbert G. Sayer

Blood (2008) 112 (11): 2210.

https://doi.org/10.1182/blood.V112.11.2210.2210

Published: 2008

Journal Articles

Long-Term Survival after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation in AML-Patients Is Consistently Sustained and Influenced by Donor Type Selection.

Herbert G. Sayer, MD, Lars-Olof Muegge, MD, Sebastian Scholl, MD, Kristina Schilling, MD, Anne Klink, Volker Schmidt, Klaus Hoeffken, MD

Blood (2007) 110 (11): 5087.

https://doi.org/10.1182/blood.V110.11.5087.5087

Published: 2007

Journal Articles

First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation.

Anne Klink, Christoph Kasper, M.D., Sebastian Scholl, M.D., Lars-Olof Muegge, M.D., Kristina Schilling, Anja Markusch, Klaus Hoeffken, M.D., Herbert G. Sayer, M.D.

Blood (2004) 104 (11): 1833.

https://doi.org/10.1182/blood.V104.11.1833.1833

Published: 2004

NARROW

Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

High Overall Response Rate in Calcineurin Inhibitor-Free Treatment with the mTOR Inhibitor Everolimus in Advanced Extensive Chronic GvHD after Allogeneic Stem Cell Transplantation.

Long-Term Survival after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation in AML-Patients Is Consistently Sustained and Influenced by Donor Type Selection.

First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

High Overall Response Rate in Calcineurin Inhibitor-Free Treatment with the mTOR Inhibitor Everolimus in Advanced Extensive Chronic GvHD after Allogeneic Stem Cell Transplantation.

Long-Term Survival after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation in AML-Patients Is Consistently Sustained and Influenced by Donor Type Selection.

First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only